Role of calcium in neurodegeneration

被引：0
|
作者：
Jerzy W. Łazarewicz
Elżbieta Ziemińska
Elżbieta Salińska
机构：
[1] Department of Neurochemistry Mossakowski Medical Research Centre,Laboratory of Pharmaconeurochemistry
来源：
Pharmacological Reports | 2010年 / 62卷 / 2期
关键词：
D O I：
10.1016/S1734-1140(10)70293-0
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：440 / 443
页数：3
相关论文
共 50 条
  • [41] ROLE OF MITOCHONDRIA IN MODELS OF NEURODEGENERATION
    NICKLAS, WJ
    SONSALLA, PK
    ZEEVALK, GD
    JOURNAL OF NEUROCHEMISTRY, 1993, 61 : S245 - S245
  • [42] The Potential Role of BMAA in Neurodegeneration
    Caller, Tracie
    Henegan, Patricia
    Stommel, Elijah
    NEUROTOXICITY RESEARCH, 2018, 33 (01) : 222 - 226
  • [43] Tauopathy and neurodegeneration: A role for stress
    Sierra-Fonseca, Jorge A.
    Gosselink, Kristin L.
    NEUROBIOLOGY OF STRESS, 2018, 9 : 105 - 112
  • [44] News on the role of carnosinase in neurodegeneration
    Bellia, F.
    Rizzarelli, E.
    Grasso, G.
    JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 2014, 19 : S263 - S263
  • [45] The role of microbial amyloid in neurodegeneration
    Friedland, Robert P.
    Chapman, Matthew R.
    PLOS PATHOGENS, 2017, 13 (12)
  • [46] The role of α-synuclein in neurodegeneration - An update
    Jellinger, Kurt A.
    TRANSLATIONAL NEUROSCIENCE, 2012, 3 (02) : 75 - 122
  • [47] Role of neuroinflammation in neurodegeneration development
    Weifeng Zhang
    Dan Xiao
    Qinwen Mao
    Haibin Xia
    Signal Transduction and Targeted Therapy, 8
  • [48] The neurobiology of sirtuins and their role in neurodegeneration
    Donmez, Gizem
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2012, 33 (09) : 494 - 501
  • [49] The role of microglia in the development of neurodegeneration
    Aigul R. Saitgareeva
    Kirill V. Bulygin
    Ilgiz F. Gareev
    Ozal A. Beylerli
    Leila R. Akhmadeeva
    Neurological Sciences, 2020, 41 : 3609 - 3615
  • [50] The Role of Endoproteolytic Processing in Neurodegeneration
    Wilson, Cornelia M.
    Mushtaq, Gohar
    Kamal, Mohammad A.
    Terro, Faraj
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2016, 15 (10) : 1222 - 1230
12345